Frequently Asked Questions
Factors such as increasing number of research and development activities, as well as the adoption of advanced techniques are the major growth driving factors.
Illumina, Inc. (U.S.), Epigentek Group Inc (U.S.), CD Genomics (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Novogene Co., Ltd. (China), PerkinElmer, Inc. (U.S.), Promega Corporation (U.S.), BGI (China), Nebula Genomics (U.S.), Agilent Technologies (U.S.), Qiagen (Germany), Macrogen Inc. (South korea), Oxford Nanopore Technologies plc. (U.K.), Veritas (U.S.) are the major companies operating in this market.
North America dominates the whole genome bisulfite sequencing (WGBS) market due to the surging levels of investment for the development of the healthcare industry along with the growth of new technologies.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 owing to the increasing number of population suffering from diabetes.
